recommending their use. Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use CDT only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Medicare contractors are required to develop and disseminate Articles. The size and location of the lesion must be included in the documentation. "JavaScript" disabled. If you are experiencing any technical issues related to the search, selecting the 'OK' button to reset the search data should resolve your issues. This is the American ICD-10-CM version of D04.9 - other international versions of ICD-10 D04.9 may differ. For purpose of this exclusion, "the term 'usually' means more than 50 percent of the time for all Medicare beneficiaries who use the drug. Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. Popular urban legend Hi, Tis: carcinoma in situ. an effective method to share Articles that Medicare contractors develop. As the post above indicates, there is an Excludes1 note, but it is incorrect in stating that they may not be billed together. will not infringe on privately owned rights. authorized with an express license from the American Hospital Association. You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. Hi An official website of the United States government. Codes with a subcategory listing further specify laterality. COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors EFFECTIVE: 01/01/2021 . Complete absence of all Bill Types indicates Note: . 635 0 obj <>stream Draft articles are articles written in support of a Proposed LCD. edit checks by using the ICD-O-1 code book. hbbd```b``+A$S2Xd,@$k5XDO0y LlU@&0&y*&F`I 30,` VF Includes Basal Cell, Squamous Cell and Carcinoma In Situ of Skin Background . Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (, malignant neoplasm of skin of genital organs (, Primary malignant neoplasm of skin of left shoulder, Primary malignant neoplasm of skin of left upper limb. Please do not use this feature to contact CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not Another option is to use the Download button at the top right of the document view pages (for certain document types). Cutaneous squamous-cell carcinoma is the second most common skin cancer, accounting for over 1 million cases in the United States each year.. Thyroid []. No fee schedules, basic unit, relative values or related listings are included in CPT. Another option is to use the Download button at the top right of the document view pages (for certain document types). The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11620, 11621, 11622, 11623, 11624, and 11626. A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. Squamous cell carcinoma of the anus (C210) is reportable. Key words: that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes. The codes for squamous cell carcinoma are under category C44 Other and unspecified malignant neoplasm of skin. He is an alumnus of York College of Pennsylvania and Clemson University. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use CDT only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Objectives: To determine patient and disease characteristics, treatment patterns and long-term outcomes, in order to help direct management of patients with VIN 3, to examine the risk of development of cancer following a diagnosis of VIN 3 and the risk of recurrent disease requiring multiple treatment episodes, and to review patients with vulval cancer, in order to establish the relative . [*]Carcinoma in situ of skin of neck Medicaid and the State Children's Health Insurance Programs, contracts with certain organizations to assist in the administration Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (. how would you code the excessive bleeding from SCC of the left side of nose and most of the left cheek? For example, there is no way in ICD to distinguish between an adenocarcinoma of the lung and a squamous cell carcinoma of the lung: both would be coded to C34.9. Non-small cell lung cancer (NSCLC) accounts for up to 85% of all malignant neoplasms of this localization. CPT codes, descriptions and other data only are copyright 2022 American Medical Association. The submitted CPT/HCPCS code must describe the service performed. A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. Stage 0: tis: carcinoma in situ; n0: no regional lymph node metastasis; m0: no distant metastasis. and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only License to use CPT for any use not authorized herein must be obtained through the AMA, CPT Intellectual Property Services, AMA Plaza 330 N. Wabash Ave., Suite 39300, Chicago, IL 60611-5885. (carcinoma in situ of skin), excludes basal and squamous cell in situ lesions D13.7 Benign neoplasm of endocrine pancreas Note: Effective 1/1/2021: Review this code to look for the following which were . [QUOTE="mbellar, post: 509227, member: 180067"] D04.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. All neoplasms are classified in this chapter, whether they are functionally active or not. If you are a particularly observant medical coder you8217ve probably noticed that many codes identified as deleted were actually promoted to new roles. Bowen's disease: squamous cell carcinoma in situ Bowen's disease is a premalignant condition that clinically presents as an asymptomatic, scaly or crusted plaque on the skin. He has been covering medical coding and billing, healthcare policy, and the business of medicine since 1999. Applicable FARS/HHSARS apply. However, services performed for any given diagnosis must meet all of the indications and limitations stated in the LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules. 8 [QUOTE="thomas7331, post: 507729, member: 5404"] For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Notice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. All rights reserved. All neoplasms are classified in this chapter, whether they are functionally active or not. The term carcinoma in situ (or CIS) . . . The submitted CPT/HCPCS code must describe the service performed. Earn CEUs and the respect of your peers. Usual type vulval intraepithelial neoplasia recipient email address(es) you enter. THE UNITED STATES Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. You can use the Contents side panel to help navigate the various sections. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. Healthcare providers are granted even more latitude for use of telehealth services during the COVID19 public health emergency. I hope this helps!! Billable - D04.0 Carcinoma in situ of skin of lip Billable - D04.10 Carcinoma in situ of skin of unspecified eyelid, including canthus The AMA does not directly or indirectly practice medicine or dispense medical services. Applications are available at the AMA Web site, http://www.ama-assn.org/go/cpt. The Table of Neoplasms should be used to identify the correct topography code. complete information, CMS does not guarantee that there are no errors in the information displayed on this web site. The views and/or positions Other risk factors for SCC include: To assign the most appropriate ICD-10-CM code for squamous cell carcinoma, clinical documentation should indicate: ICD-10-CM chapter 2 contains codes for most benign and malignant neoplasms. Squamous cell carcinoma (80703; arises mostly in lower third of cervix; 90% of all cervical cancers; also called epidermoid carcinoma) Squamous carcinoma in situ with questionable stromal invasion (80762) The term vulval intraepithelial neoplasia describes two conditions with different biological behaviour: usual type and differentiated type. %PDF-1.5 % C44.02 Squamous cell carcinoma of skin of lip Example 32 Coding of Neoplasms in ICD-10-CM This page displays your requested Article. Thank you for your comment. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11600, 11601, 11602, 11603, 11604, and 11606. q_r7ds1A"TTD`3i6`q@Jia$D/ %]/_ The submitted medical record must support the use of the selected ICD-10-CM code(s). Please review and accept the agreements in order to view Medicare Coverage documents, which may include licensed information and codes. The views and/or positions presented in the material do not necessarily represent the views of the AHA. FAQ icd 10 code for basal cell carcinoma of nose What is the ICD 10 for basal cell carcinoma of skin? There are multiple ways to create a PDF of a document that you are currently viewing. Primary malignant neoplasms overlapping site boundaries. The American Hospital Association ("the AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. Use of CDT is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). C44.13- Sebaccous cell carcinoma of skin of eyelid, including canthus Note: Effective 10/1/2018 . For example, 173.22:Squamous cell carcinoma of the skin of the ear and external auditory canal. It is derived from cells within the epidermis that make keratin the horny protein that makes up skin, hair and nails. If you are looking for a specific code, use your browser's Find function (Ctrl-F) to quickly locate the code in the article. Check out the dx block of D04.4. Cutaneous SCC is an invasive disease, referring to cancer cells that have grown beyond the epidermis. Proper coding is C44.02Squamous cell carcinoma of skin of lip. hb```@( f p,&}5y5LJ"%%%3th/ $84C@1(6H(\Fed 6#V3gYq can we bill dx M54.42 and M51.16 together? descriptions may not be removed, copied, or utilized within any software, product, service, solution or derivative work Article document IDs begin with the letter "A" (e.g., A12345). recommending their use. Applicable Federal Acquisition Regulation Clauses (FARS)/Department of Defense Federal Acquisition Regulation supplement (DFARS) Restrictions Apply to Government Use. HPV-related oropharyngeal squamous cell carcinoma (OPSCC) is associated with a favorable prognosis, yet patients of color and low socioeconomic status (SES) continue to experience inferior outcomes. 7500 Security Boulevard, Baltimore, MD 21244. C44.02 Squamous cell carcinoma of skin of lip For purpose of this exclusion, "the term 'usually' means more than 50 percent of the time for all Medicare beneficiaries who use the drug. The Centers for Medicare 38 Medicaid Services CMS wants your comment on the FY 2018 Inpatient Prospective Payment System and Long Term Acute Care HospitalProposed RulebyJune 13 2017. If you do not agree with all terms and conditions set forth herein, click below on the button labeled "I do not accept" and exit from this computer screen. 2. The document is broken into multiple sections. C44.82 Squamous cell carcinoma of overlapping sites of skin In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material. This email will be sent from you to the Sign up to get the latest information about your choice of CMS topics in your inbox. preparation of this material, or the analysis of information provided in the material. required field. D04.4 would be incorrect as this is documented neither [I]in situ [/I]nor as a carcinoma of the skin. Conjunctival squamous cell carcinoma (conjunctival SCC) and corneal intraepithelial neoplasia comprise what are called ocular surface squamous cell neoplasias. All Rights Reserved. As in ICD-9-CM, there is a separate Table of Neoplasms. It is the providers responsibility to select codes carried out to the highest level of specificity and selected from the ICD-10-CM code book appropriate to the year in which the service is rendered for the claim(s) submitted. You, your employees and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees and agents. AHA copyrighted materials including the UB‐04 codes and It begins in the squamous cells, which comprise most of the skins epidermis. malignant, in situ, benign, etc. Squamous cell carcinoma (80703) Occurs in 8% of all bladder carcinomas. C44.32- Squamous cell carcinoma of skin of other an unspecified parts of face If the "INDICATOR" is set to "1" additional codes from ICD-O-3 code book were used. ICD-10 code (8010-8045) Epithelial neoplasms, NOS (8050-8080) Squamous cell neoplasms . The 2023 edition of ICD-10-CM D04.9 became effective on October 1, 2022. Codes with a subcategory listing further specify laterality. MACs are Medicare contractors that develop LCDs and Articles along with processing of Medicare claims. Local Coverage Articles are a type of educational document published by the Medicare Administrative Contractors (MACs). C44.72- Squamous cell carcinoma of skin of lower limb, including hip 625 0 obj <>/Filter/FlateDecode/ID[<300BF5E799812D49BBFB4D9A3883AA65>]/Index[604 32]/Info 603 0 R/Length 104/Prev 172627/Root 605 0 R/Size 636/Type/XRef/W[1 3 1]>>stream CPT codes, descriptions and other data only are copyright 2022 American Medical Association. CPT is a trademark of the American Medical Association (AMA). Applicable FARS\DFARS Restrictions Apply to Government Use. All Rights Reserved (or such other date of publication of CPT). [LIST] of the Medicare program. Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, C44.311 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Billing and Coding articles typically include CPT/HCPCS procedure codes, ICD-10-CM diagnosis codes, as well as Bill Type, Revenue, and CPT/HCPCS Modifier codes. The AMA assumes no liability for data contained or not contained herein. . The code lists in the article help explain which services (procedures) the related LCD applies to, the diagnosis codes for which the service is covered, or for which the service is not considered reasonable and necessary and therefore not covered. Leiomyosarcoma 88903; rare tumor arising in the muscle layer of the bladder. The Centers for Medicare & Medicaid Services (CMS), the federal agency responsible for administration of the Medicare, Compliance with the provisions in LCD L33818, Excision of Malignant Skin Lesions may be monitored and addressed through post payment data analysis and subsequent medical review audits. The scope of this license is determined by the AMA, the copyright holder. It often arises within solar/ actinic keratosis or within squamous cell carcinoma in situ. that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes. Also, you can decide how often you want to get updates. I hope this helps you. article does not apply to that Bill Type. The Table of Neoplasms should be used to identify the correct topography code. Your MCD session is currently set to expire in 5 minutes due to inactivity. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. End User License Agreement: Alerts and Notices Synopsis Cutaneous squamous cell carcinoma in situ (SCCis), also known as Bowen disease, is defined histopathologically by malignant keratinocytes that involve the full thickness of the epidermis. required field. All those not listed under the ICD-10- Codes that Support Medical Necessity section of this article. CDT is a trademark of the ADA. Squamous cell carcinoma of skin of lip C44.09 . I have had this denial as well, sent appeal stating these are two separate lesions and unrelated conditions- appeals are still being upheld However, services performed for any given diagnosis must meet all of the indications and limitations stated in the LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules. Refer to the LCD for reasonable and necessary requirements and limitations. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT for resale and/or license, transferring copies of CDT to any party not bound by this agreement, creating any modified or derivative work of CDT, or making any commercial use of CDT. authorized with an express license from the American Hospital Association. "Invasive" squamous cell carcinomas are the type that grow inward and may spread. This treatment is often used for small or very superficial squamous cell cancers of the skin. This First Coast Billing and Coding Article for Local Coverage Determination (LCD) L33813 Destruction of Malignant Skin Lesions provides billing and coding guidance for frequency limitations as well as diagnosis limitations that support diagnosis to procedure code automated denials. Codes should be selected from the table. Note: Squamous cell carcinoma of the perianal skin (C445) is : not : . Please note that if you choose to continue without enabling "JavaScript" certain functionalities on this website may not be available. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. "JavaScript" disabled. Please enable "JavaScript" and revisit this page or proceed with browsing CMS.gov with Carcinoma in situ of the cervix (CIN III-8077/2) and Prostatic Intraepithelial Carcinoma (PIN III-8148/2) are not reportable. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11620, 11621, 11622, 11623, 11624, and 11626. A federal government website managed and paid for by the U.S. Centers for Medicare & Medicaid Services. MACs are Medicare contractors that develop LCDs and Articles along with processing of Medicare claims. [/QUOTE] Get crucial instructions for accurate ICD-10-CM D04 coding with all applicable Excludes 1 and Excludes 2 notes from the section level conveniently shown with each code. This would be most appropriately reported using the excision of benign lesion codes 11400-11446. Complete absence of all Revenue Codes indicates CMS and its products and services are Verrucous carcinoma is a type of squamous cell carcinoma (SCC) that can develop in your gums and cheeks the oral cavity as well as your genitals and feet. - C44.02 (squamous cell carcinoma of skin of lip) - 173.02 (squamous cell carcinoma of skin Best answers. Privacy Policy | Terms & Conditions | Contact Us. Noninvasive can be used as a synonym for in situ, ICD-O-3 behavior code /2. Neither the United States Government nor its employees represent that use of such information, product, or processes The scope of this license is determined by the AMA, the copyright holder. Draft articles have document IDs that begin with "DA" (e.g., DA12345). CMS and its products and services are not endorsed by the AHA or any of its affiliates. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 17260, 17261, 17262, 17263, 17264, 17266, 17270, 17271, 17272, 17273, 17274, 17276, 17280, 17281, 17282, 17283, 17284, 17286. Neither the United States Government nor its employees represent that use of such information, product, or processes Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license. We are looking for thought leaders to contribute content to AAPCs Knowledge Center. The remaining 15% is accounted for by small cell carcinoma. Tanning bed use. The CPT code should reflect the knowledge, skill, time and effort that the provider invests in the excision of the lesion. Applications are available at the American Dental Association web site. You can collapse such groups by clicking on the group header to make navigation easier. Example 1: A patient returns to the dermatologist to discuss removal of his SCC on his lower lip. Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes. Some articles contain a large number of codes. End Users do not act for or on behalf of the CMS. The Table of Neoplasms should be used to identify the correct topography code. ICD-10 code D04 for Carcinoma in situ of skin is a medical classification as listed by WHO under the range - Neoplasms . Laser therapy. Code History. Instructions for enabling "JavaScript" can be found here. This email will be sent from you to the ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, L33818 - Excision of Malignant Skin Lesions, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER OVER 4.0 CM, Malignant melanoma of other part of trunk, Malignant melanoma of unspecified upper limb, including shoulder, Malignant melanoma of right upper limb, including shoulder, Malignant melanoma of left upper limb, including shoulder, Malignant melanoma of unspecified lower limb, including hip, Malignant melanoma of right lower limb, including hip, Malignant melanoma of left lower limb, including hip, Merkel cell carcinoma of other part of trunk, Merkel cell carcinoma of unspecified upper limb, including shoulder, Merkel cell carcinoma of right upper limb, including shoulder, Merkel cell carcinoma of left upper limb, including shoulder, Merkel cell carcinoma of unspecified lower limb, including hip, Merkel cell carcinoma of right lower limb, including hip, Merkel cell carcinoma of left lower limb, including hip, Unspecified malignant neoplasm of anal skin, Unspecified malignant neoplasm of skin of breast, Unspecified malignant neoplasm of skin of other part of trunk, Basal cell carcinoma of skin of other part of trunk, Squamous cell carcinoma of skin of breast, Squamous cell carcinoma of skin of other part of trunk, Other specified malignant neoplasm of anal skin, Other specified malignant neoplasm of skin of breast, Other specified malignant neoplasm of skin of other part of trunk, Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder, Unspecified malignant neoplasm of skin of right upper limb, including shoulder, Unspecified malignant neoplasm of skin of left upper limb, including shoulder, Basal cell carcinoma of skin of unspecified upper limb, including shoulder, Basal cell carcinoma of skin of right upper limb, including shoulder, Basal cell carcinoma of skin of left upper limb, including shoulder, Squamous cell carcinoma of skin of unspecified upper limb, including shoulder, Squamous cell carcinoma of skin of right upper limb, including shoulder, Squamous cell carcinoma of skin of left upper limb, including shoulder, Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder, Other specified malignant neoplasm of skin of right upper limb, including shoulder, Other specified malignant neoplasm of skin of left upper limb, including shoulder, Unspecified malignant neoplasm of skin of unspecified lower limb, including hip, Unspecified malignant neoplasm of skin of right lower limb, including hip, Unspecified malignant neoplasm of skin of left lower limb, including hip, Basal cell carcinoma of skin of unspecified lower limb, including hip, Basal cell carcinoma of skin of right lower limb, including hip, Basal cell carcinoma of skin of left lower limb, including hip, Squamous cell carcinoma of skin of unspecified lower limb, including hip, Squamous cell carcinoma of skin of right lower limb, including hip, Squamous cell carcinoma of skin of left lower limb, including hip, Other specified malignant neoplasm of skin of unspecified lower limb, including hip, Other specified malignant neoplasm of skin of right lower limb, including hip, Other specified malignant neoplasm of skin of left lower limb, including hip, Malignant neoplasm of unspecified upper limb, Malignant neoplasm of unspecified lower limb, Malignant neoplasm of other specified ill-defined sites, Melanoma in situ of breast (skin) (soft tissue), Melanoma in situ of unspecified upper limb, including shoulder, Melanoma in situ of right upper limb, including shoulder, Melanoma in situ of left upper limb, including shoulder, Melanoma in situ of unspecified lower limb, including hip, Melanoma in situ of right lower limb, including hip, Melanoma in situ of left lower limb, including hip, Carcinoma in situ of skin of unspecified upper limb, including shoulder, Carcinoma in situ of skin of right upper limb, including shoulder, Carcinoma in situ of skin of left upper limb, including shoulder, Carcinoma in situ of skin of unspecified lower limb, including hip, Carcinoma in situ of skin of right lower limb, including hip, Carcinoma in situ of skin of left lower limb, including hip, Unspecified malignant neoplasm of skin of scalp and neck, Basal cell carcinoma of skin of scalp and neck, Squamous cell carcinoma of skin of scalp and neck, Other specified malignant neoplasm of skin of scalp and neck, Malignant neoplasm of overlapping sites of vulva, Malignant neoplasm of other specified female genital organs, Malignant neoplasm of overlapping sites of female genital organs, Malignant neoplasm of overlapping sites of penis, Malignant neoplasm of head, face and neck, Secondary malignant neoplasm of genital organs, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of unspecified female genital organs, Carcinoma in situ of other female genital organs, Carcinoma in situ of unspecified male genital organs, Carcinoma in situ of other male genital organs, Malignant neoplasm of external lip, unspecified, Malignant neoplasm of upper lip, inner aspect, Malignant neoplasm of lower lip, inner aspect, Malignant neoplasm of lip, unspecified, inner aspect, Malignant neoplasm of commissure of lip, unspecified, Malignant neoplasm of overlapping sites of lip, Malignant neoplasm of dorsal surface of tongue, Malignant neoplasm of ventral surface of tongue, Malignant neoplasm of anterior two-thirds of tongue, part unspecified, Malignant neoplasm of overlapping sites of tongue, Malignant neoplasm of tongue, unspecified, Malignant neoplasm of anterior floor of mouth, Malignant neoplasm of lateral floor of mouth, Malignant neoplasm of overlapping sites of floor of mouth, Malignant neoplasm of floor of mouth, unspecified, Malignant neoplasm of overlapping sites of palate, Malignant neoplasm of palate, unspecified, Malignant neoplasm of overlapping sites of unspecified parts of mouth, Malignant neoplasm of overlapping sites of other parts of mouth, Malignant neoplasm of submandibular gland, Malignant neoplasm of major salivary gland, unspecified, Malignant neoplasm of tonsillar pillar (anterior) (posterior), Malignant neoplasm of overlapping sites of tonsil, Malignant neoplasm of tonsil, unspecified, Malignant neoplasm of anterior surface of epiglottis, Malignant neoplasm of lateral wall of oropharynx, Malignant neoplasm of posterior wall of oropharynx, Malignant neoplasm of overlapping sites of oropharynx, Malignant neoplasm of oropharynx, unspecified, Malignant neoplasm of superior wall of nasopharynx, Malignant neoplasm of posterior wall of nasopharynx, Malignant neoplasm of lateral wall of nasopharynx, Malignant neoplasm of anterior wall of nasopharynx, Malignant neoplasm of overlapping sites of nasopharynx, Malignant neoplasm of nasopharynx, unspecified, Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect, Malignant neoplasm of posterior wall of hypopharynx, Malignant neoplasm of overlapping sites of hypopharynx, Malignant neoplasm of hypopharynx, unspecified, Malignant neoplasm of pharynx, unspecified, Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx, Malignant melanoma of unspecified eyelid, including canthus, Malignant melanoma of right upper eyelid, including canthus, Malignant melanoma of right lower eyelid, including canthus, Malignant melanoma of left upper eyelid, including canthus, Malignant melanoma of left lower eyelid, including canthus, Malignant melanoma of unspecified ear and external auricular canal, Malignant melanoma of right ear and external auricular canal, Malignant melanoma of left ear and external auricular canal, Malignant melanoma of unspecified part of face, Malignant melanoma of other parts of face, Malignant melanoma of overlapping sites of skin, Merkel cell carcinoma of unspecified eyelid, including canthus, Merkel cell carcinoma of right upper eyelid, including canthus, Merkel cell carcinoma of right lower eyelid, including canthus, Merkel cell carcinoma of left upper eyelid, including canthus, Merkel cell carcinoma of left lower eyelid, including canthus, Merkel cell carcinoma of unspecified ear and external auricular canal, Merkel cell carcinoma of right ear and external auricular canal, Merkel cell carcinoma of left ear and external auricular canal, Merkel cell carcinoma of unspecified part of face, Merkel cell carcinoma of other parts of face, Merkel cell carcinoma of overlapping sites, Unspecified malignant neoplasm of skin of lip, Other specified malignant neoplasm of skin of lip, Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus, Unspecified malignant neoplasm of skin of right upper eyelid, including canthus, Unspecified malignant neoplasm of skin of right lower eyelid, including canthus, Unspecified malignant neoplasm of skin of left upper eyelid, including canthus, Unspecified malignant neoplasm of skin of left lower eyelid, including canthus, Basal cell carcinoma of skin of unspecified eyelid, including canthus, Basal cell carcinoma of skin of right upper eyelid, including canthus, Basal cell carcinoma of skin of right lower eyelid, including canthus, Basal cell carcinoma of skin of left upper eyelid, including canthus, Basal cell carcinoma of skin of left lower eyelid, including canthus, Squamous cell carcinoma of skin of unspecified eyelid, including canthus, Squamous cell carcinoma of skin of right upper eyelid, including canthus, Squamous cell carcinoma of skin of right lower eyelid, including canthus, Squamous cell carcinoma of skin of left upper eyelid, including canthus, Squamous cell carcinoma of skin of left lower eyelid, including canthus, Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus, Sebaceous cell carcinoma of skin of right upper eyelid, including canthus, Sebaceous cell carcinoma of skin of right lower eyelid, including canthus, Sebaceous cell carcinoma of skin of left upper eyelid, including canthus, Sebaceous cell carcinoma of skin of left lower eyelid, including canthus, Other specified malignant neoplasm of skin of unspecified eyelid, including canthus, Other specified malignant neoplasm of skin of right upper eyelid, including canthus, Other specified malignant neoplasm of skin of right lower eyelid, including canthus, Other specified malignant neoplasm of skin of left upper eyelid, including canthus, Other specified malignant neoplasm of skin of left lower eyelid, including canthus, Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal, Unspecified malignant neoplasm of skin of right ear and external auricular canal, Unspecified malignant neoplasm of skin of left ear and external auricular canal, Basal cell carcinoma of skin of unspecified ear and external auricular canal, Basal cell carcinoma of skin of right ear and external auricular canal, Basal cell carcinoma of skin of left ear and external auricular canal, Squamous cell carcinoma of skin of unspecified ear and external auricular canal, Squamous cell carcinoma of skin of right ear and external auricular canal, Squamous cell carcinoma of skin of left ear and external auricular canal, Other specified malignant neoplasm of skin of unspecified ear and external auricular canal, Other specified malignant neoplasm of skin of right ear and external auricular canal, Other specified malignant neoplasm of skin of left ear and external auricular canal, Unspecified malignant neoplasm of skin of unspecified part of face, Unspecified malignant neoplasm of skin of nose, Unspecified malignant neoplasm of skin of other parts of face, Basal cell carcinoma of skin of unspecified parts of face, Basal cell carcinoma of skin of other parts of face, Squamous cell carcinoma of skin of unspecified parts of face, Squamous cell carcinoma of skin of other parts of face, Other specified malignant neoplasm of skin of unspecified parts of face, Other specified malignant neoplasm of skin of nose, Other specified malignant neoplasm of skin of other parts of face, Unspecified malignant neoplasm of overlapping sites of skin, Basal cell carcinoma of overlapping sites of skin, Squamous cell carcinoma of overlapping sites of skin, Other specified malignant neoplasm of overlapping sites of skin, Carcinoma in situ of oral cavity, unspecified site, Carcinoma in situ of labial mucosa and vermilion border, Carcinoma in situ of gingiva and edentulous alveolar ridge, Melanoma in situ of unspecified eyelid, including canthus, Melanoma in situ of right upper eyelid, including canthus, Melanoma in situ of right lower eyelid, including canthus, Melanoma in situ of left upper eyelid, including canthus, Melanoma in situ of left lower eyelid, including canthus, Melanoma in situ of unspecified ear and external auricular canal, Melanoma in situ of right ear and external auricular canal, Melanoma in situ of left ear and external auricular canal, Melanoma in situ of unspecified part of face, Carcinoma in situ of skin of unspecified eyelid, including canthus, Carcinoma in situ of skin of right upper eyelid, including canthus, Carcinoma in situ of skin of right lower eyelid, including canthus, Carcinoma in situ of skin of left upper eyelid, including canthus, Carcinoma in situ of skin of left lower eyelid, including canthus, Carcinoma in situ of skin of unspecified ear and external auricular canal, Carcinoma in situ of skin of right ear and external auricular canal, Carcinoma in situ of skin of left ear and external auricular canal, Carcinoma in situ of skin of unspecified part of face, Carcinoma in situ of skin of other parts of face, Some older versions have been archived.